$153 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 100 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OCX | Exit | ONCOCYTE CORP | $0 | – | -39,725 | -100.0% | -0.05% | – |
| ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -375,000 | -100.0% | -0.10% | – |
| GE | Exit | GENERAL ELECTRIC CO | $0 | – | -18,760 | -100.0% | -0.11% | – |
| KRMD | Exit | REPRO MED SYS INC | $0 | – | -18,000 | -100.0% | -0.12% | – |
| BNGO | Exit | BIONANO GENOMICS INC | $0 | – | -470,000 | -100.0% | -0.28% | – |
| FUL | Exit | FULLER H B COMPANY | $0 | – | -7,400 | -100.0% | -0.31% | – |
| INTC | Exit | INTEL CORP | $0 | – | -8,750 | -100.0% | -0.42% | – |
| HTGM | Exit | HTG MOLECULAR DIAGNOSTICS IN | $0 | – | -2,426,300 | -100.0% | -0.74% | – |
| APPS | Exit | DIGITAL TURBINE INC | $0 | – | -30,200 | -100.0% | -0.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
| LILY ELI & CO | 41 | Q3 2023 | 6.9% |
| PFIZER INC | 41 | Q3 2023 | 2.9% |
| ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
| EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
| CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
| DONALDSON INC | 41 | Q3 2023 | 1.3% |
| VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
| US BANCORP DEL | 41 | Q3 2023 | 0.8% |
| BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
| FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
| Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
| Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
| CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
| TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
| Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
| TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
| BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
| EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-22 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-07-21 |
| SC 13G/A | 2023-05-15 |
| 13F-HR | 2023-05-09 |
| SC 13G/A | 2023-02-09 |
| SC 13G | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.